Parathyroid neoplasms: Clinical, histopathological, and tissue microarray-based molecular analysis

Human Pathology

Volumn 34, Issue 1, 2003, Pages 54-64

  Stojadinovic, Alexander ^a   Hoos, Axel ^a   Nissan, Aviram ^a   Dudas, Maria E ^a   Cordon Cardo, Carlos ^a   Shaha, Ashok R ^a   Brennan, Murray F ^a   Singh, Bhuvanesh ^a   Ghossein, Ronald A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Bcl 2; Cyclin D1; Immunohistochemistry; Ki 67; mdm2; P21; P27; P53; Parathyroid tumor; Tissue microarray

Indexed keywords

CYCLIN D1; KI 67 ANTIGEN; MOLECULAR MARKER; PROTEIN BCL 2; PROTEIN MDM2; PROTEIN P21; PROTEIN P27; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CELL INVASION; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR BIOLOGY; PARATHYROID ADENOMA; PARATHYROID CARCINOMA; PHENOTYPE; PROTEIN EXPRESSION; SURVIVAL RATE;

EID: 0037255944     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2003.55     Document Type: Article

References (37)

1. Koea JB, Shaw JH: Parathyroid cancer: Biology and management. Surg Oncol 8:155-165, 1999
2. Ghandur-Mnaymneh L, Kimura N: The parathyroid adenoma: A histopathologic definition with a study of 172 cases of primary hyperparathyroidism. Am J Pathol 115:70-83, 1984
3. Schantz A, Castleman B: Parathyroid carcinoma: A study of 70 cases. Cancer 31:600-605, 1973
4. rd series, Fascicle-6), Rosai J, Sobin L (eds). Armed Forces Institute of Pathology: Washington, DC, 1993
5. Abbona GC, Papotti M, Gasparri G, et al: Proliferative activity in parathyroid tumors as detected by Ki-67 immunostaining. Hum Pathol 26:135-138, 1995
6. Vargas MP, Vargas HI, Kleiner DE, et al: The role of prognostic markers (MIB-1, RB, and bcl-2) in the diagnosis of parathyroid tumors. Mod Pathol 10:12-17, 1997
7. Erickson LA, Jin L, Wollan P, et al: Parathyroid hyperplasia, adenomas, and carcinomas: Differential expression of p27 protein. Am J Surg Pathol 23:288-295, 1999
8. Vasef MA, Brynes RK, Sturm M, et al: Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: A paraffin immunohistochemical study. Mod Pathol 12:412-416, 1999
9. Naccarato AG, Marcocci C, Miccoli P, et al: Bcl-2, p53 and MIB-1 expression in normal and neoplastic parathyroid tissues. J Endocrinol Invest 21:136-141, 1998
10. Levine AJ, Momand J, Finlay CA: The p53 tumor suppressor gene. Nature 351:453-456, 1991
11. Cordon-Cardo C: Mutation of cell cycle regulators: Biological and clinical implications for human neoplasia. Am J Pathol 147: 545-560, 1997
12. Buglioni S, D'Agnano I, Cosimelli M, et al: Evaluation of multiple bio-pathological factors in colorectal adenocarcinomas: Independent prognostic role of p53 and Bcl-2. Int J Cancer 84:545-552, 1999
13. Wang W, Johansson H, Kvasnicka T, et al: Detection of apoptotic cells and expression of Ki-67 antigen, Bcl-2, p53 oncoproteins in human parathyroid adenoma. APMIS 104:789-796, 1996
14. Hoos A, Urist MJ, Stojadinovic A, et al: Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol 158: 1245-1251, 2001
15. Kononen J, Bubendorf L, Kallioniemi A, et al: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4:844-847, 1998
16. Altman DG: Describing data, in Altman DG (ed): Practical Statistics for Medical Research. London, Chapman and Hall, 1996, 404-408
17. Mehta C, Patel N: A network algorithm for performing Fisher's exact test in rXc contingency tables. J Am Stat Assoc 78: 427-434, 1983
18. Fisher RA, Yates F: Statistical Tables for Biological, Agricultural and Medical Research (ed 6). Edinburgh, Oliver & Boyd, 1964, Appendix B
19. Kaplan E, Meier P: Nonparametric Nonparametiic estimation from incomplete observations. J Am Statist Assoc 53:457-481, 1958
20. Peto R, Peto J: Asymptotically efficient rank invariant procedures. J R Stat Soc A 135:185-207, 1972
21. Snover DC, Foukar K: Mitotic activity in benign parathyroid disease. Am J Clin Pathol 75:345-347, 1981
22. San Juan J, Monteagudo C, Fraker D, et al: Significance of mitotic activity and other morphologic parameters in parathyroid adenomas: Correlation with clinical behavior. Am J Clin Pathol 92: 523, 1989 (abstr)
23. Kishikawa S, Shan L, Ogihara K, et al: Overexpression and genetic abnormality of p53 in parathyroid adenomas. Pathol Int 49:853-857, 1999
24. Karak AK, Sarkar S, Chumber S, et al: MIB-1 proliferative index in parathyroid adenoma and hyperplasia. Indian J Med Res 105:235-238, 1997
25. Hsi ED, Zuckerburg LR, Yang W, et al: Cyclin D1/PRAD1 expression in parathyroid adenomas: An immunohistochemical study. J Clin Endocrinol Metab 81:1736-1739, 1996
26. Kameyama K, Takami H, Umemura S, et al: PCNA and Ki-67 as prognostic markers in human parathyroid carcinomas. Ann Surg Oncol 7:301-305, 2000
27. Hakim JP, Levine MA: Absence of p53 point mutations in parathyroid adenomas and carcinomas. J Clin Endocrinol Metab 78:103-106, 1994
28. Zhang H, Xeong Y, Beach D: Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Mol Biol Cell 4:897-906, 1993
29. Ogawa M, Maeda K, Onoda N, et al: Loss of p21WAF1/DIP1 expression correlates with disease progression in gastric carcinoma. Br J Cancer 75:1617-1620, 1997
30. Zirbes TK, Baldus SE, Moeing SP, et al: Prognostic impact of p31/waf1/cip1 in colorectal cancer. Int J Cancer 89:14-18, 2000
31. Stein JP, Ginsberg DA, Grossfeld GD, et al: Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer. J Natl Cancer Inst 90:1072-1079, 1998
32. Chao DT, Korsmayer SJ: Bcl-2 family: Regulators of cell death. Ann Rev Immunol 16:395-419, 1998
33. Fero ML, Rivkin M, Tasch M, et al: A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27 (Kip1)-deficient mice. Cell 85:733-744, 1996
34. Hemmer S, Wasenius VM, Haglund C, et al: Deletion of 11q23 and cyclin D1 overexpression are frequent aberrations in parathyroid adenomas. Am J Pathol 158:1355-1362, 2001
35. Hoos A, Lewis JJ, Antonescu CR, et al: Characterization of molecular abnormalities in human fibroblastic neoplasms - A model for genotype-phenotype association in soft tissue tumors. Cancer Res 61:3171-3175, 2001
36. Vetto JT, Brennan MF, Woodruff JM, et al: Parathyroid carcinoma: Diagnosis and clinical history. Surgery 114: 883-893, 1993
37. Flye MW, Brennan MF: Surgical resection of metastatic parathyroid carcinoma. Ann Surg 193:425-435, 1981